Planned Methadone Treatment for Heroin Admissions

The DASIS Report:  Planned Methadone Treatment for Heroin Admissions

• HTML format

• PDF format

Highlights

• Methadone is an opioid agonist medication used to treat heroin and other opiate addiction.  Methadone reduces the craving for heroin and other opiates by blocking the receptor sites that are affected by heroin or other opiates. 

• Methadone treatment was planned for 40 percent of all heroin admissions reported to SAMHSA's Treatment Episode Data Set (TEDS) in 2000.  Injection was more likely to be reported as the route for heroin administration by heroin admissions with planned methadone treatment (70 percent) than those with no planned methadone treatment (59 percent). 

• The planned use of methadone to treat heroin addiction varied by State.  The nine States with the highest proportion of planned methadone treatment were:  California, Colorado, Indiana, Hawaii, Iowa, Ohio, Alaska, North Carolina, and New Jersey.

• Heroin admissions with planned methadone treatment were twice as likely as admissions with no planned methadone treatment to be employed full time (25 vs. 12 percent). 

Other reports on treatment

Other topics

Other OAS publications and services

This Short Report, The DASIS Report:  Planned Methadone Treatment for Heroin Admissions,  is based on the Drug and Alcohol Services Information System (DASIS), the primary source of national data on substance abuse treatment.  DASIS is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA). 

This page has been accessed 62479 times since 6/19/03.

This page was last updated on June 19, 2008.

What's New